Home ::

Hormone Refractory Prostate News

Hormone Refractory Prostate - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
JEVTANA Black Triangle Refused For Men With Advanced
JEVTANA is the first of recently licensed drugs for the treatment of metastatic read more...
Disappointment for Men With Advanced
Docetaxel for the treatment of read more...
Treatment Options in Castration-Resistant
Castration-resistant read more...
Dendreon Highlights The Best Of The Web
Provenge is an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant ( read more...
Provenge And NeuVax: A Tale Of 2 Marvels
Dendreon received the FDA's approval to market Provenge in April of 2010 for asymptomatic or minimally symptomatic read more...
Dendreon Announces Presentation of PROVENGE Data at the 2012 American Society of Clinical Oncology Annual Meeting
PROVENGE Indication and Important Safety Information PROVENGE is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant ( read more...